SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 59 filers reported holding SUNESIS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $15,000 | 0.0% | 27,851 | 0.0% | 0.00% | – |
| Q1 2016 | $15,000 | -40.0% | 27,851 | 0.0% | 0.00% | – |
| Q4 2015 | $25,000 | +8.7% | 27,851 | 0.0% | 0.00% | – |
| Q3 2015 | $23,000 | -74.2% | 27,851 | -6.0% | 0.00% | – |
| Q2 2015 | $89,000 | -95.1% | 29,622 | -96.0% | 0.00% | – |
| Q1 2015 | $1,806,000 | +9.9% | 736,648 | +14.4% | 0.00% | – |
| Q4 2014 | $1,643,000 | -57.9% | 644,126 | +17.8% | 0.00% | – |
| Q3 2014 | $3,902,000 | +23.6% | 546,682 | +12.8% | 0.00% | – |
| Q2 2014 | $3,158,000 | +11.7% | 484,762 | +13.4% | 0.00% | – |
| Q1 2014 | $2,826,000 | -26.3% | 427,307 | -50.1% | 0.00% | – |
| Q4 2013 | $3,832,000 | +76.2% | 856,045 | +95.3% | 0.00% | – |
| Q3 2013 | $2,175,000 | -2.0% | 438,390 | +2.9% | 0.00% | – |
| Q2 2013 | $2,219,000 | – | 426,069 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,136,000 | $7,997,000 | 1.56% |
| Healthcare Value Capital, LLC | 200,000 | $510,000 | 0.93% |
| DSC Advisors, L.P. | 450,000 | $1,148,000 | 0.33% |
| Alden Global Capital Ltd | 188,200 | $480,000 | 0.12% |
| Perceptive Advisors | 500,000 | $1,275,000 | 0.11% |
| Baker Brothers Advisors | 3,200,000 | $8,160,000 | 0.08% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 653,970 | $1,668,000 | 0.07% |
| BALYASNY ASSET MANAGEMENT L.P. | 2,346,948 | $5,985,000 | 0.06% |
| Visium Asset Management, LP | 1,528,356 | $3,898,000 | 0.06% |
| Northeast Financial Consultants Inc | 11,000 | $28,000 | 0.02% |